Learn how AbbVie and Ironwood can help you save on LINZESS. Call 1-855-226-3937 or click to LEARN MORE ▸

Skip to Main content
  • Prescribing Information
  • Medication Guide
  • Healthcare Professionals
Linzess logo
  • En Español
  • Cost & Savings
  • WHY LINZESS
    • How LINZESS Can Help
    • How LINZESS Works
    • Side Effects of LINZESS
    • LINZESS Patient Experiences
  • UNDERSTANDING CONSTIPATION
    • Types of Constipation
    • What is IBS-C
    • What is CIC
    • Constipation Treatment Options
    • Tips for Managing Constipation
    • Pediatric Functional Constipation
  • FIND RELIEF
    • Talk to a Doctor
    • Check My Symptoms
    • How to Take LINZESS
  • STARTING LINZESS
    • LINZESS Savings Program
    • Healthy Routines
    • Wellness Tips
    • Community Resources
    • Sign Up for Support
    • FAQs
  • CHECK MY SYMPTOMS
  • GET SAVINGS NOW
  • HEALTHCARE PROFESSIONALS
  • COST & SAVINGS
  • EN ESPAÑOL
CHECK MY SYMPTOMS
TALK TO A DOCTOR ONLINE
CHECK MY SYMPTOMS

LEGAL POLICY

Terms of Use

Updated: April 4, 2018

These Terms of Use are a binding agreement between you, AbbVie and Ironwood, and govern your access and use of the Site, which includes any information, data, tools, products, services and other content (together, "Content") available on or through the Site.

PLEASE READ THESE TERMS OF USE CAREFULLY BEFORE ENTERING THE SITE. EACH TIME YOU ENTER THE SITE, YOUR USE INDICATES YOUR FULL ACCEPTANCE OF AND AGREEMENT TO ABIDE BY THESE TERMS OF USE IN THEIR THEN CURRENT FORM. IF YOU DO NOT ACCEPT THE TERMS AND CONDITIONS STATED IN THESE TERMS OF USE, PLEASE EXIT THE SITE.

As we may revise these Terms of Use from time to time, you should review them periodically.

AbbVie and Ironwood grant you a limited right to use the Site only for your own private, non-commercial informational purposes only, and to print pages from the Site only in connection with that use. You may not modify, distribute, transmit, perform, reproduce, publish, license, create derivative works from, transfer or sell any Content, including any text, graphics, logos and other source-identifying symbols, designs, icons, images, or other information, software or code obtained from the Site. You are prohibited from removing any copyright, trademark or other proprietary notice or legend contained on (or printed from) the Site or on any printed pages. In addition, you are prohibited from decomposing, decompiling, reverse engineering, disassembling or otherwise deconstructing all or any portion of the Site.

Medical Advice Disclaimer

NO INFORMATION IN THIS SITE IS PROVIDED WITH THE INTENTION TO GIVE MEDICAL ADVICE OR INSTRUCTIONS ON THE ACCURATE USE OF ABBVIE AND IRONWOOD PRODUCTS. ABBVIE AND IRONWOOD CANNOT ANSWER UNSOLICITED E-MAILS REQUESTING PERSONAL MEDICAL ADVICE.

VISITORS SHOULD ALWAYS CONSULT A HEALTHCARE PROFESSIONAL PRIOR TO MAKING ANY DECISIONS, OR UNDERTAKING ANY ACTIONS OR NOT UNDERTAKING ANY ACTIONS RELATED TO ANY HEALTH CARE PROBLEM OR ISSUE YOU MIGHT HAVE AT ANY TIME, NOW OR IN THE FUTURE.

Privacy Statement

AbbVie’s and Ironwood’s Privacy Statement is a part of these Terms of Use. Use of this Site indicates your consent to the collection and use of your Personal Data as set forth in the Privacy Statement.

Copyrights and Trademarks

The Site and the Content contain copyrighted materials, trademarks, and other proprietary materials that are owned by AbbVie and Ironwood, its affiliates and/or third parties and are protected by intellectual property laws of the United States and other countries.

You should assume that all Content of the Site is copyrighted unless otherwise noted and may not be used, copied, reproduced, downloaded, modified, published, distributed, transmitted, or exploited, in whole or in part, in any form or by any means, without the express written permission of AbbVie and Ironwood or the original creator of the material, except as provided herein.

Product names, logos, trademarks, and service marks that are used or displayed on the Site (collectively, the “Trademarks”) are registered or unregistered trademarks and the exclusive property of AbbVie, Ironwood, or their affiliates. No use of the Trademarks may be made without AbbVie’s and Ironwood’s prior written authorization, except to identify the product or services of the company. Other product names, logos, trademarks, and service marks appearing on the Site that are not owned by AbbVie or Ironwood may not be used without express permission from their respective owners.

Nothing contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right, either express or implied, under any intellectual property of AbbVie, Ironwood, or any third party.

User Responsibility; Limitations on Liability; Disclaimer of Warranties

Each person assumes full responsibility and all risks arising from use of the Site.

IN NO EVENT, INCLUDING BUT NOT LIMITED TO NEGLIGENCE, SHALL ANY OF ABBVIE, IRONWOOD, THEIR AFFILIATES, AND THEIR RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, REPRESENTATIVES, DATA PROVIDERS, AND LICENSORS AND THEIR RESPECTIVE HEIRS AND ASSIGNS BE LIABLE TO YOU OR ANY THIRD PARTY FOR ANY DAMAGES OF ANY KIND OR NATURE, INCLUDING, BUT NOT LIMITED TO, DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY, SPECIAL (INCLUDING LOSS OF PROFIT), PUNITIVE, OR OTHER DAMAGES ARISING FROM OR IN CONNECTION WITH THE EXISTENCE OR USE OF THE SITE, REGARDLESS OF WHETHER ABBVIE, IRONWOOD, OR ANY OF THE OTHER ENTITIES OR PERSONS LISTED ABOVE HAS BEEN ADVISED AS TO THE POSSIBILITY OF SUCH DAMAGES. THIS INCLUDES DAMAGES TO, OR FOR VIRUSES THAT MAY INFECT YOUR COMPUTER EQUIPMENT.

IF YOU RELY ON THIS SITE OR ANY INFORMATION, PRODUCT OR SERVICE AVAILABLE THROUGH THIS SITE, YOU AGREE THAT YOU DO SO AT YOUR OWN RISK. THERE MAY BE DELAYS, OMISSIONS, INTERRUPTIONS, INACCURACIES, AND/OR OTHER PROBLEMS WITH THE INFORMATION, PRODUCTS, AND SERVICES PUBLISHED ON OR PROMOTED OVER THIS SITE.

WITHOUT LIMITING THE FOREGOING, EVERYTHING ON THE SITE IS PROVIDED TO YOU AS IS AND ABBVIE AND IRONWOOD MAKE NO REPRESENTATIONS OR WARRANTIES OF ANY KIND OR NATURE WITH RESPECT TO THE SITE.

ABBVIE AND IRONWOOD HEREBY DISCLAIM ALL REPRESENTATIONS AND WARRANTIES, WHETHER EXPRESS OR IMPLIED, CREATED BY LAW, CONTRACT OR OTHERWISE, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTIBILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, OR NON-INFRINGEMENT.

ABBVIE AND IRONWOOD MAKE NO REPRESENTATION OR WARRANTY THAT ACCESS TO THE SITE WILL BE AVAILABLE ON A TIMELY BASIS, WILL BE UNINTERRUPTED, OR THAT THE DATA CONTAINED ON THE SITE WILL BE TIMELY OR ERROR FREE.

Please note that some jurisdictions may not allow the exclusion of implied warranties, so some of the above exclusions may not apply to you. Check your local laws for any restrictions or limitations regarding the exclusion of implied warranties. To the extent that AbbVie and Ironwood may not, as a matter of applicable law, disclaim any implied warranty or limit its liabilities, the scope and duration of such warranty and the extent of AbbVie’s and Ironwood’s liability will be equal to the minimum permitted under such applicable law.

Indemnification

YOU AGREE TO INDEMNIFY AND HOLD HARMLESS ABBVIE, IRONWOOD, THEIR AFFILIATES, AGENTS, VENDORS AND LICENSORS, AND THEIR RESPECTIVE EMPLOYEES, OWNERS AND REPRESENTATIVES AGAINST ANY AND ALL CLAIMS, OF WHATEVER NATURE, THAT ARISE OUT OF ANY BREACH BY YOU OF THIS AGREEMENT OR YOUR USE OF THIS SITE, TO THE FULLEST EXTENT ALLOW BY LAW.

You further agree that any claim related to this Site must be filed within one year after it arises.

Non-Personal Data

Any non-Personal Data that you transmit to, or post on, this Site by electronic mail or otherwise, including any data, questions, comments, suggestions, or the like, is, and will be treated as, non-confidential and nonproprietary data, and AbbVie and Ironwood shall have no obligation of any kind with respect to such data. AbbVie, Ironwood and any of our affiliates may use such data for any purpose whatsoever in accordance with applicable laws and regulations, including, but not limited to, the following purposes: reproduction, disclosure, transmission, publication, broadcast, and further posting. Further, we and any of our affiliates shall be free to use such data, including, but not limited to, any ideas, concepts, know-how, or techniques contained therein, for any purpose whatsoever, including, but not limited to, researching, developing, manufacturing, and marketing products incorporating such data. Please consult our Privacy Statement for more information.

Links to Other Websites

You are free to establish a hypertext link to this Site so long as the link does not state or imply any endorsement or sponsorship of you, your company, or your site by AbbVie and Ironwood. Without the prior written permission of AbbVie and Ironwood, you may not frame or scrape any of the content on the site nor incorporate into another website or other service any intellectual property of AbbVie and Ironwood.

Links to AbbVie’s and Ironwood’s Websites

AbbVie and Ironwood encourage other websites to link to this Site, provided that these links comply with the guidelines set forth herein. Links to this Site from other sites should be text-only and may not include AbbVie’s or Ironwood’s logo or other intellectual property. We strictly prohibit any suggestions of AbbVie or Ironwood endorsement or recommendation of a specific company, product, or service.

Links From AbbVie’s and Ironwood’s Websites

This Site may include links to other sites. These links are provided solely for purposes of convenience. AbbVie and Ironwood are not responsible for the content or accuracy of data contained on other sites or other sites’ privacy practices. AbbVie and Ironwood are not liable for any damages or injury arising from content contained on other sites. Links to third-party sites are not a referral or endorsement of any other entity, item, or service. You release AbbVie, Ironwood, and their affiliates from any damages that you may incur, and agree not to assert any claims against them, arising from your purchase or use of third-party supplied data, products and services.

Jurisdiction

Nothing contained on the Site should be construed as solicitation or promotion for any product or for the use of any product in a way which is not authorized by the country in which the reader is physically located. This Site provides information about products or uses that may not be available in particular countries. Some of the products mentioned may in certain countries be approved or cleared by regulatory authorities for sale or use with different indications, dosages, and restrictions.

Forward-Looking Statements

This Site contains information that is forward-looking and involves risks and uncertainties, including, without limitation, risks and uncertainties of research and development, clinical development, regulatory approvals and the regulatory process, our reliance on third-party manufacturers, product commercialization, competition, patents, product liability, and third party reimbursement, and other risks and uncertainties detailed from time to time in our periodic reports filed with the Securities and Exchange Commission. Actual results may differ materially from such forward-looking information.

Reservation of Rights

AbbVie and Ironwood reserve the right to alter or delete material from this Site at any time without notice. Please check often for updates, as we reserve the right, in our sole discretion, to modify these Terms of Use at any time, and your use of the Site indicates your acceptance of any revisions to these terms.

These Terms of Use and any other terms and conditions of service on the Site constitute the entire agreement between you and AbbVie and Ironwood and govern your use of the Site. AbbVie’s or Ironwood’s failure to enforce any right or provision of these Terms of Use shall not constitute a waiver of such right or provision. If any provision of these Terms of Use is unlawful, void, or unenforceable, then it shall be severed and shall not affect the validity and enforceability of any Terms of Use. If any provision of these Terms of Use is held to be invalid or unenforceable in any jurisdiction, such provision shall be deemed modified to the minimum extent necessary so that such provision shall no longer be held to be invalid or unenforceable, and these Terms of Use shall be interpreted so as to achieve the intent expressed herein to the greatest extent possible in the jurisdiction in question. Any such modification, invalidity or unenforceability shall be strictly limited both to such provision and to such jurisdiction.

AbbVie or Ironwood may assign its ownership, control, or other rights to any party at any time without any notice to you. Your rights and duties cannot be assigned without AbbVie’s or Ironwood’s written consent. Nothing in these Terms of Use provides any third party with any remedy, claim, or cause of action.

USES

LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt). 
  • Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take LINZESS, tell your doctor about your medical conditions, including if you are:

  • Pregnant or plan to become pregnant. It is not known if LINZESS will harm your unborn baby.
  • Breastfeeding or plan to breastfeed. You and your doctor should decide if you will take LINZESS and breastfeed.


Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.


Side Effects

LINZESS can cause serious side effects, including diarrhea, which is the most common side effect and can sometimes be severe. Diarrhea often begins within the first 2 weeks of LINZESS treatment. Stop taking LINZESS and call your doctor right away if you get severe diarrhea during treatment with LINZESS.

Other common side effects of LINZESS in people with IBS-C and CIC include gas, stomach-area (abdomen) pain, and swelling, or a feeling of fullness or pressure in your abdomen (distention).

Call your doctor or go to the nearest hospital emergency room right away if you develop unusual or severe stomach-area (abdomen) pain, especially if you also have bright red, bloody stools or black stools that look like tar.

These are not all the possible side effects of LINZESS. For more information, ask your doctor or pharmacist. 

Please see full Prescribing Information, including Boxed Warning, and Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie and Ironwood may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.

US-LIN-250020

WHY LINZESS
  • How LINZESS Can Help
  • How LINZESS Works
  • Side Effects of LINZESS
  • LINZESS Patient Experiences
UNDERSTANDING CONSTIPATION
  • Types of Constipation
  • What Is IBS-C
  • What Is CIC
  • Pediatric Functional Constipation
  • Constipation Treatment Options
  • Tips for Managing Constipation
FIND RELIEF
  • Talk to a Doctor
  • Check My Symptoms
  • How to Take LINZESS
STARTING LINZESS
  • LINZESS Savings Program
  • Healthy Routines
  • Wellness Tips
  • Community Resources
  • Sign Up for Support
  • FAQs
  • Ironwood California Privacy Policy
  • Accessibility Statement
  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Consumer Health Data Privacy Notice
  • Cookies Settings
  • Your Privacy Choices
  • Sitemap

AbbVie® and its design are trademarks of AbbVie Inc.
Ironwood® and its three-leaf design are registered trademarks of Ironwood Pharmaceuticals, Inc. LINZESS® and its design are registered trademarks of Ironwood Pharmaceuticals, Inc. From the Gut℠ is a service mark of Allergan Sales, LLC, an AbbVie company.

The product information provided in this site is intended only for residents of the United States. The products discussed on this site may have different product labeling outside of the United States. The health information described in this site is provided for educational purposes only and is not intended to substitute for discussions with a healthcare provider.


  • Abbvie logo
  • Ironwood logo
  • © 2024 AbbVie and Ironwood Pharmaceuticals, Inc. All rights reserved. 

↑ Back to top

US-LIN-210575 03/23

Linzess logo

For Healthcare Professionals

This information provided on this website is intended for U.S. healthcare professionals only.

I certify that I am a U.S. Healthcare Professional.

No
YES

For adults with Irritable Bowel Syndrome with Constipation (IBS-C) or Chronic Idiopathic Constipation (CIC)

TALK TO A DOCTOR ONLINE TODAY*

Answer a few quick questions about your symptoms.

Connect with a doctor online to find out if it could be IBS-C or CIC.

If approved, pick up your prescription from your local pharmacy.

*Third-party website; does not constitute an endorsement or recommendation by AbbVie. A fee will be charged by the telemedicine provider.

Acknowledge and Continue
Cancel

You are now leaving LINZESS.com

By clicking “Acknowledge and Continue” above, you acknowledge and agree that neither AbbVie nor Ironwood does, in any way, endorse or recommend UpScript, a telemedicine provider, the qualifications of any physician associated with UpScript, or the quality of medical care any of those physicians can provide. You also acknowledge and agree that neither AbbVie nor Ironwood makes any guarantees that using UpScript will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie and Ironwood recommend that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE, IRONWOOD, AND THEIR RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE UPSCRIPT WEBSITE. If you agree to the above, click “Acknowledge and Continue” to proceed to the UpScript website. If you do not agree to the above, click “Cancel” to remain on LINZESS.com.

TALK TO A DOCTOR ONLINE

Did you know you can talk to a doctor today from the comfort of your home? Connect with a healthcare professional online about your symptoms.

NO THANKS
GET STARTED

YOU ARE NOW LEAVING LINZESS.COM

Links to other websites are provided as a service to you. AbbVie and Ironwood Pharmaceuticals accept no responsibility for the content of other websites.

Would you like to continue?

No
Yes

YOU ARE NOW LEAVING LINZESS.COM

Links to third-party content are provided as a convenience for informational purposes only. They are not meant to replace your healthcare provider’s medical advice or treatment. The organizations listed have not endorsed AbbVie and Ironwood or any of their respective products or services. AbbVie and Ironwood have listed these sites only as a convenience and according to the permissions granted by their respective terms of use. Each organization has its own terms and conditions and privacy policy that you should read if you choose to contact any of them.

Would you like to continue?

No
Yes

Transcript

Share

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

You are leaving an AbbVie hosted website.

You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the content of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.​

Conversely, the presence of this link does not imply the linked site’s endorsement of AbbVie.

​Do you wish to leave this site?​

No
Yes

US-LIN-230431-WOL

USES

LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
  • Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take LINZESS, tell your doctor about your medical conditions, including if you are:

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).

USES

LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
  • Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take LINZESS, tell your doctor about your medical conditions, including if you are:

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).

USES

LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt). 
  • Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take LINZESS, tell your doctor about your medical conditions, including if you are:

  • Pregnant or plan to become pregnant. It is not known if LINZESS will harm your unborn baby.
  • Breastfeeding or plan to breastfeed. You and your doctor should decide if you will take LINZESS and breastfeed.


Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.


Side Effects

LINZESS can cause serious side effects, including diarrhea, which is the most common side effect and can sometimes be severe. Diarrhea often begins within the first 2 weeks of LINZESS treatment. Stop taking LINZESS and call your doctor right away if you get severe diarrhea during treatment with LINZESS.

Other common side effects of LINZESS in people with IBS-C and CIC include gas, stomach-area (abdomen) pain, and swelling, or a feeling of fullness or pressure in your abdomen (distention).

Call your doctor or go to the nearest hospital emergency room right away if you develop unusual or severe stomach-area (abdomen) pain, especially if you also have bright red, bloody stools or black stools that look like tar.

These are not all the possible side effects of LINZESS. For more information, ask your doctor or pharmacist. 

Please see full Prescribing Information, including Boxed Warning, and Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie and Ironwood may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.

US-LIN-250020